logo-large
  • Browse Categories

Publications by authors named "Andrea Mattsson"

Claim this Profile
S
Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin.
Robin Myte, Andrea Mattsson, Matt Poole, Dustin J Little, Per Nyström

Circ Heart Fail· December 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
Lars H Lund, Carolyn S P Lam, Patricia E Pizzato, Anders Gabrielsen, Erik Michaëlsson, Andrea Mattsson

Eur J Heart Fail· September 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of COVID-19 on the Initiation of Clinical Trials in Europe and the United States.
Florian Lasch, Eftychia-Eirini Psarelli, Ralf Herold, Andrea Mattsson, Lorenzo Guizzaro

Clin Pharmacol Ther· May 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: